|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|
| Current assets – cash | ||||||
| Deferred offering costs | ||||||
| Current assets | ||||||
| Cash | ||||||
| Due from Sponsor | ||||||
| Prepaid expenses | ||||||
| Total current assets | ||||||
| Prepaid expenses – non-current | ||||||
| Cash and marketable securities held in Trust Account | ||||||
| TOTAL ASSETS | ||||||
| Accrued offering costs | ||||||
| Promissory note – related party | ||||||
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||||||
| Current liabilities – accounts payable and accrued expenses | ||||||
| Warrant liabilities | ||||||
| Deferred underwriting fee payable | ||||||
| TOTAL LIABILITIES | ||||||
| Class A ordinary shares subject to possible redemption; 41,400,000 shares issued and outstanding, at redemption value | ||||||
| SHAREHOLDERS’ DEFICIT | ||||||
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 10,350,000 shares issued and outstanding | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| TOTAL SHAREHOLDERS’ DEFICIT | ||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT |
Loading...
